| impurities list of API molecules | |||||||||||||
|
|||||||||||||
| 165. | Olanzapine |
|
2-Methyl-4-(4-methyl-4-oxido-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
174794-02-6 |
N-Oxide |
|||||||||||
| 166. | Olanzapine |
|
2-Methyl-4-(1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
161696-76-0 |
Piperazine imp |
|||||||||||
| 167. | Olanzapine |
|
1-(Chloromethyl)-1-methyl-4-(2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)-piperazinium Chloride |
719300-59-1 |
IMP-C |
|||||||||||
| 168. | Oseltamivir |
|
(3R,4R,5S)-Ethyl 4-(N-tert-butylacetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate hydrochloride |
|
tert – Butyl acetamide |
|||||||||||
| 169. | Oseltamivir |
|
(3aR,4R,7aR)-6-(Ethoxycarbonyl)-3a,4,5,7a-tetrahydro-2,2-dimethylbenzo[d][1,3]dioxol-4-yl methanesulfonate |
|
Mesyl shikmate imp |
|||||||||||
| 170. | Oseltamivir |
|
Methyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
|
WHO Imp-D (Methyl ester) |
|||||||||||
| 171. |
Paroxetin .HCl |
|
4-((4-(4-Fluorophenyl)piperidin-3-yl)methoxy)benzene-1,2-diol |
|
Diol imp |
|||||||||||
| 172. |
Paroxetin |
|
4-((4-(4-Fluorophenyl)piperidin-3-yl)methoxy)-2-methoxyphenol |
|
Vaniline related metabolite |
|||||||||||
| 173. | Paroxetin |
|
5-((4-(4-Fluorophenyl)piperidin-3-yl)methoxy)-2-methoxyphenol |
|
Isovaniline related metabolite |
|||||||||||
| 174. | Paroxetin |
|
((3S,4R)-4-(4-Fluorophenyl) |
|
EP Imp-I |
|||||||||||
| 175. | Paroxetin |
|
((3S,4R)-1-Benzyl-4-(4-fluorophenyl)piperidin-3-yl)methanol |
|
EP Imp-H |
|||||||||||
| 176. |
Paroxetin |
|
4-(4-Fluorophenyl)-1,2,3,6-tetrahydro-1-methylpyridine |
1012886-75-7 |
USP RC-E (EP Imp-G) |
|||||||||||
| 177. |
Paliperidone |
|
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
761460-08-6 |
N-Oxide |
|||||||||||
| 178. |
Paliperidone |
|
3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8-dihydro-2-methyl-6H-pyrido[1,2-a]pyrimidine-4,9-dione |
1189516-65-1 |
Keto imp |
|||||||||||
| 179. |
Pantoprazole |
|
5-(Difluoromethoxy)-1H-benzo[d]imidazole-2-thiol |
97963-62-7 |
Benzimidazole |
|||||||||||
| 180. | Pantoprazole |
|
6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-1-oxido-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole |
953787-55-8 |
Sulfone N-Oxide |
|||||||||||
| 181. |
Pantoprazole
|
|
2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-5-(difluoromethoxy)-1-methyl-1H-benzo[d]imidazole |
127780-16-9
|
Sulfone |
|||||||||||
| 182. | Pantoprazole |
|
2-((3,4-Dimethoxypyridin-2-yl)methylsulfinyl)-6-(difluoromethoxy)-1-methyl-1H-benzo[d]imidazole |
|
IMP-D |
|||||||||||
| 183. | Pantoprazole |
|
2-((3,4-Dimethoxypyridin-2-yl)methylsulfinyl)-6-(difluoromethoxy)-1-methyl-1H-benzo[d]imidazole |
|
IMP-F |
|||||||||||
| 184. | Pioglitazone HCl |
|
5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione |
952188-00-0 |
Dimer Impurity |
|||||||||||
| 185. | Prasugrel |
|
5-Acetyl-4,5,6,7-tetrahydro |
|
Diacetyl impurity |
|||||||||||
| 186. | Pyronaridine Tetraphosphate |
|
4-(7-Chloro-2-methoxybenzo |
|
Aminoalcohol impurity |
|||||||||||
| 187. | Pyronaridine Tetraphosphate |
|
4-(7-chloro-2-methoxybenzo |
|
Monosubstituted imp |
|||||||||||
| 188. | Quetiapine |
|
Quetiapine N-methyl impurity |
|
N-methyl imp |
|||||||||||
| 189. |
Quetiapine Fumarate
|
|
Quetiapine piperzine dihydrochloride |
|
||||||||||||
| 190. | Quetiapine Fumarate |
|
2-[2-(4-Dibenzo [b,f][1,4]thia |
|
|
|||||||||||
| 191. |
|
|
Dibenzo[b,f][1,4]thiazepine-11(10H)one(Quetiapine Related compound-G) |
|
RC-G |
|||||||||||
| 192 | Quinapril |
|
|
|
EP Imp-G |
|||||||||||
| 193. |
Quinapril
|
|
|
|
EP Imp-H |
|||||||||||
|
||||||||||||||||